February 24, 2026 · Form 4 insider transaction
Salvadori Daniel Gesua Sive bought 89,226 shares of Abbott Laboratories at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 29,742 on February 24, 2027, 29,742 on February 24, 2028, and 29,742 on February 24, 2029.